Royal Bank of Canada
AUTL

Royal Bank of Canada’s Autolus Therapeutics AUTL Stock Holding History

Royal Bank of Canada’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$20K – 7095
2025
Q4 		$20K Sell
10,000
-11,897
-54% -$18.3K ﹤0.01% 6034
2025
Q3 		$36K Buy
21,897
+19,629
+865% +$38.3K ﹤0.01% 5958
2025
Q2 		$5K Buy
+2,268
New +$3.75K ﹤0.01% 6625
2025
Q1 		– Sell
-682
Closed -$2K – 6795
2024
Q4 		$2K Buy
+682
New +$2.31K ﹤0.01% 6692
2024
Q2 		– Sell
-17
Closed – – 7029
2024
Q1 		$0 Hold
17
– – ﹤0.01% 6996
2023
Q4 		$0 Hold
17
– – ﹤0.01% 7093
2023
Q3 		$0 Buy
17
+1
+6% +$3 ﹤0.01% 7066
2023
Q2 		$0 Sell
16
-19,996
-100% -$47.4K ﹤0.01% 7231
2023
Q1 		$37K Buy
20,012
+19,956
+35,636% +$39K ﹤0.01% 5773
2022
Q4 		$0 Buy
56
+12
+27% +$30 ﹤0.01% 7206
2022
Q3 		$0 Hold
44
– – ﹤0.01% 7428
2022
Q2 		$0 Hold
44
– – ﹤0.01% 7357
2022
Q1 		$0 Buy
44
+2
+5% +$8 ﹤0.01% 7721
2021
Q4 		$0 Sell
42
-98
-70% -$588 ﹤0.01% 7640
2021
Q3 		$1K Buy
140
+80
+133% +$505 ﹤0.01% 7447
2021
Q2 		$0 Sell
60
-216
-78% -$1.34K ﹤0.01% 7463
2021
Q1 		$2K Buy
276
+162
+142% +$1.2K ﹤0.01% 7217
2020
Q4 		$1K Buy
114
+111
+3,700% +$1.18K ﹤0.01% 6918
2020
Q3 		$0 Buy
+3
New +$44 ﹤0.01% 6603

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada's AUTL Position: Q1 2026 in Review

Royal Bank of Canada sold out of Autolus Therapeutics (AUTL) in Q1 2026, closing a stake of 10,000 shares — an estimated $20K sold.

Royal Bank of Canada first reported a position in AUTL in Q3 2020 and held it in 19 quarters. The position peaked at $37K in Q1 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q1 2026.

  • Royal Bank of Canada reported no remaining Autolus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 10,000 Autolus Therapeutics shares in Q1 2026, an estimated $20K.
  • Royal Bank of Canada first reported a position in Autolus Therapeutics in Q3 2020 and held it in 19 quarters.
  • Royal Bank of Canada's Autolus Therapeutics position peaked at $37K in Q1 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.